The IMID Forum

Prof Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib

22 Des 202021min

Prof Iain McInnes discusses JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide form...

22 Des 202020min

Past President of EULAR and Carol Nachman Prize winner. In this podcast, Professor Paul Emery discusses his work in managing early RA and the growth of his unit at Leeds into a world leading centre fo...

9 Des 202022min

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes a preview of an up...

30 Nov 202010min

Prof Stanley Cohen - University of Texas. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Stanley Cohen discusses safety profile of upadacitinib

25 Nov 202021min

Prof Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide...

25 Nov 20207min

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great efficac...

23 Nov 202031min

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great new dev...

23 Nov 202026min